A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)
- Resource Type
- Article
- Source
- In
Gynecologic Oncology 2010 118(3):308-312 - Subject
- Language
- ISSN
- 0090-8258